Skip to main content
. 2019 Sep 30;11(10):1476. doi: 10.3390/cancers11101476

Table 2.

Differentially expressed exo-miRNAs at the end of induction chemotherapy.

miRNA ID a Mean ∆CT End Mean ∆CT Onset Mean RQ End Mean RQ Onset Fold Change b Adjusted p Value c
hsa-miR-376a 3.28 1.28 0.10 0.41 −2.0 5.30E−08
hsa-miR-150 −6.04 −7.60 65.87 194.19 −1.6 9.87E−08
hsa-miR-376c 2.69 0.70 0.16 0.62 −2.0 1.48E−07
hsa-miR-132 1.33 −0.55 0.40 1.47 −1.9 5.45E−07
hsa-miR-130a 1.36 −0.49 0.39 1.40 −1.8 1.21E−05
hsa-miR-539 2.61 0.85 0.16 0.55 −1.8 3.22E−05
hsa-miR-342-3p −2.59 −3.70 6.03 12.96 −1.1 4.81E−05
hsa-miR-192 1.40 0.06 0.38 0.96 −1.3 5.95E−05
hsa-miR-340 3.02 1.78 0.12 0.29 −1.2 5.95E−05
hsa-miR-320 −4.01 −4.97 16.10 31.28 −1.0 7.29E−05
hsa-let-7g 0.24 −1.06 0.85 2.08 −1.3 9.93E−05
hsa-miR-590-5p 0.96 −0.30 0.51 1.23 −1.3 9.93E−05
hsa-miR-152 2.44 1.22 0.18 0.43 −1.2 2.27E−04
hsa-miR-146b −3.45 −4.37 10.91 20.74 −0.9 2.27E−04
hsa-miR-20a −3.86 −5.32 14.56 39.97 −1.5 3.64E−04
hsa-miR-25 −0.31 −1.69 1.24 3.23 −1.4 3.64E−04
hsa-miR-26b 0.19 −1.15 0.88 2.22 −1.3 3.64E−04
hsa-miR-324-3p 1.73 0.62 0.30 0.65 −1.1 4.52E−04
hsa-miR-199a-3p −0.01 −1.41 1.01 2.65 −1.4 4.95E−04
hsa-miR-106b −0.59 −1.75 1.50 3.36 −1.2 5.83E−04
hsa-miR-19b −4.65 −6.15 25.11 71.00 −1.5 6.23E−04
hsa-miR-374 −1.50 −2.61 2.82 6.11 −1.1 6.54E−04
hsa-miR-29c 2.42 1.03 0.19 0.49 −1.4 9.50E−04
hsa-miR-20b −1.84 −2.92 3.57 7.55 −1.1 1.03E−03
hsa-miR-26a −1.83 −3.01 3.57 8.07 −1.2 1.09E−03
hsa-miR-140-3p 3.24 2.38 0.11 0.19 −0.9 1.65E−03
hsa-miR-18a 1.47 0.31 0.36 0.80 −1.2 1.65E−03
hsa-miR-185 1.08 −0.04 0.47 1.03 −1.1 1.65E−03
hsa-miR-195 −0.71 −1.81 1.63 3.50 −1.1 1.69E−03
hsa-miR-142-3p −2.80 −4.16 6.95 17.86 −1.4 2.02E−03
hsa-miR-21 −1.44 −2.66 2.72 6.31 −1.2 2.30E−03
hsa-miR-652 1.07 −0.15 0.47 1.11 −1.2 2.41E−03
hsa-miR-19a −0.08 −1.40 1.06 2.65 −1.3 2.43E−03
hsa-let-7e −2.27 −3.31 4.81 9.94 −1.0 2.55E−03
hsa-miR-106a −5.59 −6.46 48.08 88.20 −0.9 2.55E−03
hsa-miR-660 1.40 0.29 0.38 0.82 −1.1 2.99E−03
hsa-miR-598 1.94 0.64 0.26 0.64 −1.3 3.56E−03
hsa-let-7d 0.11 −0.81 0.93 1.75 −0.9 3.73E−03
hsa-miR-24 −4.99 −5.75 31.85 53.81 −0.8 5.38E−03
hsa-miR-17 −5.42 −6.41 42.81 85.03 −1.0 5.47E−03
hsa-miR-483-5p −0.30 −1.11 1.23 2.16 −0.8 5.67E−03
hsa-miR-30b −2.76 −3.76 6.78 13.54 −1.0 5.99E−03
hsa-miR-301 1.70 0.70 0.31 0.62 −1.0 6.28E−03
hsa-miR-186 −2.53 −3.38 5.79 10.40 −0.8 8.42E−03
hsa-miR-331 −1.40 −2.13 2.63 4.38 −0.7 8.98E−03
hsa-miR-27a 0.15 −0.82 0.90 1.76 −1.0 9.19E−03
hsa-miR-15b −0.63 −1.60 1.55 3.04 −1.0 9.41E−03
hsa-miR-28 2.12 1.28 0.23 0.41 −0.8 1.14E−02
hsa-miR-345 0.70 0.05 0.61 0.96 −0.6 1.28E−02
hsa-miR-30c −3.10 −4.03 8.59 16.32 −0.9 1.29E−02
hsa-miR-103 0.95 0.13 0.52 0.91 −0.8 1.30E−02
hsa-miR-193b 1.91 1.21 0.27 0.43 −0.7 1.34E−02
hsa-miR-29a −0.84 −1.54 1.78 2.91 −0.7 1.64E−02
hsa-miR-99b 2.30 1.69 0.20 0.31 −0.6 1.64E−02
hsa-miR-328 0.69 −0.16 0.62 1.12 −0.9 1.80E−02
hsa-miR-744 0.24 −0.53 0.85 1.45 −0.8 2.78E−02
hsa-miR-425-5p 0.38 −0.23 0.77 1.18 −0.6 3.23E−02
hsa-miR-92a −2.30 −3.03 4.94 8.15 −0.7 3.23E−02
hsa-miR-16 −5.99 −6.86 63.78 116.19 −0.9 3.25E−02
hsa-miR-142-5p 2.39 1.66 0.19 0.32 −0.7 3.38E−02
hsa-miR-221 0.16 −0.73 0.90 1.66 −0.9 4.11E−02
hsa-miR-146a −5.33 −5.98 40.31 62.91 −0.6 4.30E−02

a List of differentially expressed exo-miRNAs; b Fold change defined as –∆∆CT value. Fold change lower than 0 indicates a downregulation. Fold change higher than 0.58 or lower than −0.58 was considered significant; c T test p value adjusted for multiple hypothesis testing using Benjamini-Hockberg. p value lower than 0.05 is considered significant.